Streetbeat News

Stock Prices

TSE

Trading of shares in Trinseo PLC has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 1:38 pm

IMAC

Shares of IMAC Holdings have been halted on a circuit breaker due to a significant drop in the stock price, which is now down by 15.4%.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 1:36 pm

BBBY

JPM

NVDA

TSLA

JPMorgan is reportedly working on a blockchain payment system, which has led to a spike in Bitcoin, Ethereum, and Dogecoin. Tesla's Supercharger network has expanded to 50,000 stations worldwide. NVIDIA and Reliance Industries are collaborating to create AI infrastructure. Goldman Sachs is planning further workforce reductions after earlier layoffs. Ryan Cohen is reportedly under SEC investigation over his trades in Bed Bath & Beyond.

Portfolio Pulse from Akanksha Bakshi

September 08, 2023 | 1:34 pm

ADBE

Adobe's stock has been upgraded from Neutral to Buy by Mizuho, with the price target raised from $520 to $630. This has resulted in Adobe shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 1:32 pm

ACN

ALNY

ARWR

NSC

SOFI

VFS

Jim Cramer, host of CNBC's 'Mad Money Lightning Round', gave his opinions on several stocks. He recommended buying Norfolk Southern Corporation (NSC) and SoFi Technologies, Inc. (SOFI), but advised against investing in VinFast Auto Ltd. (VFS), Arrowhead Pharmaceuticals, Inc. (ARWR), and Alnylam Pharmaceuticals, Inc. (ALNY). He also praised Accenture plc (ACN) and its CEO, Julie Sweet.

Portfolio Pulse from Lisa Levin

September 08, 2023 | 1:24 pm

BIOC

PSTV

Biocept Inc (BIOC) shares are trading higher after the company signed a non-exclusive licensing agreement for CNSide with Plus Therapeutics Inc (PSTV). The agreement expands the laboratory services agreement between the two companies. Plus Therapeutics is using CNSide in a clinical trial to treat patients with carcinomas and/or melanomas. Plus will pay Biocept an upfront fee of $150,000 in stock, plus $6,000 per CSF tumor cell enumeration analysis performed in Biocept's laboratory before the completion of the technology transfer.

Portfolio Pulse from Vandana Singh

September 08, 2023 | 1:18 pm

CVX

WDS

Workers at Chevron Corporation's (NYSE:CVX) LNG projects in Australia have gone on strike, potentially disrupting exports and raising LNG prices. The strikes began at Chevron's Gorgon and Wheatstone facilities, which accounted for about 7% of global LNG supply last year. If no deal is reached by next Wednesday, the workers plan to stop work completely for two weeks starting September 14. Woodside Energy Group Ltd (NYSE:WDS) was also initially threatened with strikes, but reached a settlement with its workforce.

Portfolio Pulse from Vandana Singh

September 08, 2023 | 1:15 pm

CLX

INGR

SJM

The most accurate Wall Street analysts recommend holding three high-yielding stocks in the consumer staples sector: The J. M. Smucker Company (SJM), The Clorox Company (CLX), and Ingredion Incorporated (INGR). These stocks have dividend yields of 3.02%, 3.08%, and 3.13% respectively. Recent news for these companies include a sales decline for SJM, better-than-expected results for CLX, and worse-than-expected earnings for INGR.

Portfolio Pulse from Lisa Levin

September 08, 2023 | 1:12 pm

EZGO

RENT

SWBI

ZUMZ

Several consumer discretionary stocks experienced significant movement in Friday's pre-market session. EZGO Technologies, Smith & Wesson Brands, Color Star Tech, Genius Gr, Faraday Future, and EBET saw gains, while Rent the Runway, Kaixin Auto Hldgs, Hooker Furnishings, BTC Digital, Zumiez, and RH experienced losses. Earnings reports influenced several of these movements.

Portfolio Pulse from Benzinga Insights

September 08, 2023 | 1:06 pm

BIOC

IMPL

NBSE

SNGX

During Friday's pre-market session, several healthcare stocks experienced significant movement. Biocept, Impel Pharmaceuticals, Senti Biosciences, ZyVersa Therapeutics, Rezolute, and Elutia saw increases in their stock prices, while Soligenix, NeuBase Therapeutics, Cyclo Therapeutics, GRI Bio, Asensus Surgical, and Palisade Bio experienced decreases.

Portfolio Pulse from Benzinga Insights

September 08, 2023 | 1:06 pm